PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study
PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study
Recruiting · NCT04819243 · Registry updated 2025-01-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| PALbociclib Endocrine Therapy Followed by Talazo Vs. Talazoz-Atezo Study | Premenopausal HR+/HER2- Metastatic Breast Cancer | Recruiting | Phase 2 | 2025-01-03 | NCT04819243 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Samsung Medical Center | 207 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Samsung medical Center | Seoul | South Korea | 2 |